The manufacturer in a recent announcement declared that it would raise the list price of all but four of the drugs by 5%, effective January 15.
Three drugs will increase by 3% while one will go up by 9%. The medications represent 10% of Pfizer’s drug portfolio.
Barbara Greene, Readers Bureau, Contributor
Edited by Jesus Chan
Do you want to add feedback to this story? Please add a comment in the e-mail box below.
Like our Facebook page https://www.facebook.com/TheReadersBureau
Follow us on Twitter https://twitter.com/readersbureau21